Main Newsletter
Mastery Series
Therapy Series
 

Items for the Week

Ordered by most recent

FDA Approves Sanofi's Diabetes Drug Toujeo

U.S. health regulators have approved Sanofi's diabetes drug Toujeo, a more potent follow-up to the drugmaker's top-selling insulin product Lantus...


One Modification of Diet Can Improve the Metabolic Syndrome

In a comparison of a fiber-intake focused diet versus the more complex AHA-compliant diet, both cohorts lost weight, although the AHA dieters lost slightly more...


Women's Risk For Diabetes Increases If Parents Smoked

Women whose mothers smoked while pregnant are two to three times as likely to be diabetic as adults....



Custom Mobile App for Nurses Diagnoses More Obesity, Smoking and Depression

A Columbia Nursing study has found that nurses equipped with a decision support smartphone app using evidence-based guidelines diagnosed more chronic health issues...


What Most Docs Don't Do: Counsel Patients on Drug Adherence

A survey revealed that only 48% routinely counseled patients when giving new prescriptions...


Eylea Bests Avastin, Lucentis in Diabetic Macular Edema

According to published data, treatment with aflibercept resulted in greater improvement in those with worse baseline levels of visual acuity...


Study Links Lack of Sleep to Type 2 Diabetes Risk

Experts say less sleep affects hormone that controls blood sugar levels...


Resistance Exercise after Dinner Decreases CVD Risk for Type 2's

Glucose and fat levels in the blood decreased among obese adults with type 2 diabetes when they exercised after a meal...


'Smart' Insulin Holds Promise for Type 1 Diabetes Patients

A novel insulin that automatically adjusts blood sugar may mitigate some of the complications associated with insulin dosing for patients with type 1 diabetes...


Breastfeeding May Lower Risk of Type 1 Diabetes

A recent study discovers that there may be an association between breastfeeding and lowering risk of type 1 diabetes...


Fatty Acids Can Be Marker for Type 2 Diabetes

High nonesterified fatty acids (NEFAs) show negative relationship to type 2 diabetes. But n-3 fatty acids (FAs) may protect against the disease...


Quality Management in Diabetes Care

Using feedback and tailored support for clinicians, healthcare can be improved...


Even Without HTN, BP Meds Benefit Diabetes Patients

A new analysis indicates that people with type 2 diabetes are less likely to suffer myocardial infarctions, strokes, or early mortality when they take blood pressure medications -- even if they don't actually have hypertension…


Increased Cancer Risk Associated with Type 1 and Type 2 Diabetes

Why is cancer risk higher among diabetes patients?...


54 Drugs with Weight Changes

Researchers examined data from 257 randomized trials to find out which drugs cause weight loss…


Does Detemir Cross the Placenta in Women with Diabetes?

The relatively new long-acting insulin analog needs to be studied to determine its absorption pharmacokinetics...


Keeping Blood Sugars Down May Delay Type 1 Diabetes Complications

Optimum HbA1c level yet to be determined...


Intensive Lifestyle Weight-loss Intervention and Metformin in the Diabetes Prevention Program

In the DPP and DPP-OS trials, diabetes was prevented or delayed with metformin or ILS when directed at weight loss and increased physical activity...


Higher Prevalence of Suicide Attempts in Adolescent Type 1 Diabetes Patients

However, advancement in medications and better controlled regimens may be contributing to a decline in psychiatric disorders among this population...


Effects of GIP and GLP-1 on Glucagon Response in Type 1 Diabetes

Glucose-dependent insulinotropic polypeptide and glucagon- like peptide-1 have glucose-dependent effects on glucagon secretion but differ in their effects on type 1 and type 2 diabetes patients…


Do Anxiety, Depression and Metabolic Syndrome Increase the Risk of Type 2?

Depressive symptoms have been associated with type 2 diabetes mellitus (T2DM), but less is known about other anxiety disorders that can be comorbid or exist without depression...


Deaf People at Higher Risk of Type 2 Diabetes

Inadequate access to primary care means that deaf people have a higher risk of developing type 2 diabetes, high blood pressure, and heart disease...


High-Protein Diets Yield Mixed Results

Popular weight loss strategy improves satiety and decreases fat mass, but increases risk of metabolic disease…


Older Diabetic Adults Who Experience Hyperglycemic Episodes Have Higher Mortality Risk

Crisis episodes signified uncontrolled diabetes and increased risk of complications...


Government Dietary Fat Guidelines Did Not Have Sufficient Supporting Evidence

Dietary recommendations introduced for 220 million US and 56 million UK citizens by 1983 did not have sufficient supporting evidence from randomized controlled trials...


Four New Alternate Blood Draw Sites with Same Response Time As Finger Tips

Using these 4 new sites for testing blood sugars will allow patients' finger tips to get back to normal...


Type 1 Women Have A 40% Greater Risk of Mortality than Men

In the meta-analysis, women also had twice the excess risk of fatal and nonfatal vascular events, compared with men with type 1 diabetes...


Bariatric Surgery for Diabetics May Not Be Worth The Risk

Life expectancy may be reduced after bariatric surgery for patients with a BMI more than 62 kg/m2 …


Effects of Prediabetes on Subsequent Cardiovascular Disease and Diabetes

In this longitudinal population-based study, 1609 patients were followed between 2002 and 2014 (mean, 10.9 years) to determine whether prediabetes affected risk for cardiovascular disease (CVD) or diabetes mellitus (DM)...


Blood Pressure Lowering in Type 2's Leads to Lower Risk of CVD and Improved Mortality

Blood pressure-lowering treatment among patients with type 2 diabetes is associated with a lower risk of cardiovascular disease (CVD) and heart disease events and improved mortality, according to a study…


The DIALBEST Trial Among Latinos with Type 2 Diabetes

Structured intervention led by Community Health Workers shows success….


Human-Insulin Producing Stem Cells

Success in finding new stem cells that can produce insulin…


Study Finds Beta Cells Not Completely Lost in Type 1 Patients

Most with long-term diagnosis foud to continue to secrete low levels of insulin...


A Look at Managing Diabetes in the Pregnant Population

Latest ADA Guidelines, published January 2015...


Type 2 Diabetes Control with GLP-1 Agonist and Basal Insulin Combination

Glucose regulation and weight management are very important factors when treating type 2 diabetes patients...


Glucose Tolerance and Diabetes Risk in Schizophrenic Patients

Due to the metabolic effects of antipsychotic medications, glucose control is very important in diabetic patients with schizophrenia…


Short-term Outcomes Worse with Glyburide for GDM

Glyburide (glibenclamide) should not be used to treat gestational diabetes mellitus (GDM) unless insulin and metformin are unavailable, the authors of a new systematic review and meta-analysis conclude...


FDA Approves Empagliflozin/Linagliptin Combination Glyxambi

Approved as an adjunctive treatment to diet and exercise for adults with type 2 diabetes...


Abnormal Glucose Tolerance Is Increasing in Sub-Saharan Africans

According to the International Diabetes Federation, by the year 2035, 41.5 million sub-Saharan Africans will be diagnosed as diabetics and 66 million will be diagnosed as pre-diabetics...


Measuring CKD and Cognitive Impairment in Type 2 African Americans

Participants with CKD had significantly poorer processing speed and working memory….



Navigate through our listing of Items for the Week articles here.
Next Last

9163 Total articles for Items for the Week


Browse our other news categories below.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Looking for a particular Newsletter Issue? Click Here

2015 Most Popular Articles:

What Is the Best Time to Exercise with Diabetes?
Posted February 05, 2015
FDA Approves Sanofi's Diabetes Drug Toujeo
Posted February 27, 2015
One Modification of Diet Can Improve the Metabolic Syndrome
Posted February 27, 2015
'Smart' Insulin Holds Promise for Type 1 Diabetes Patients
Posted February 27, 2015
Breastfeeding May Lower Risk of Type 1 Diabetes
Posted February 27, 2015
Resistance Exercise after Dinner Decreases CVD Risk for Type 2's
Posted February 27, 2015
Eylea Bests Avastin, Lucentis in Diabetic Macular Edema
Posted February 27, 2015
What Most Docs Don't Do: Counsel Patients on Drug Adherence
Posted February 27, 2015
Custom Mobile App for Nurses Diagnoses More Obesity, Smoking and Depression
Posted February 27, 2015
Women's Risk For Diabetes Increases If Parents Smoked
Posted February 27, 2015


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
What percentage of your patients are at goal for A1c, BP and cholesterol?
CME/CE of the Week
Ronald Tamler, MD,PhD,MBA

Category: General Diabetes
Credits: .75


Advertisement


Search Articles On Diabetes In Control